Application no. and date | 13723910.9 (espacenet) (Federated) (European Patent Register), 20130514 | Patent/reg. no. and date | DK/EP 2855448, 20170208 | Publication date | 20150408 | Priority no. and date | US 201261647200 P, 20120515 | EP pub. no. and date |
EP 2855448 20150408 | Effective date | | Applicant/owner | Cancer Research Technology Ltd, Angel Building 407 St John Street
London, Greater London EC1V 4AD, GB | Applicant ref. no. | P81701525DK00E | Inventor | COLLINS, Ian, The Institute of Cancer Research 15 Cotswold Road
Sutton Surrey SM2 5NG, GB, MATTHEWS, Thomas Peter, The Institute of Cancer Research 15 Cotswold Road
Sutton Surrey SM2 5NG, GB, LAINCHBURY, Michael, Argenta Discovery 2009 Limited 8-9 Spire Green Centre Flex Meadow
Harlow Essex CM19 5TR, GB, FARIA DA FONSECA MCHARDY, Tatiana, The Institute of Cancer Research 15 Cotswold Road
Sutton Surrey SM2 5NG, GB, OSBORNE, James, Biofocus Chesterford Research Park Chesterford Park
Saffron Walden Essex CB10 1XL, GB, WALTON, Michael Ian, The Institute of Cancer Research 15 Cotswold Road
Sutton Surrey SM2 5NG, GB, GARRETT, Michelle Dawn, 94 Grasmere Road Whitstable
Canterbury Kent CT5 3EU, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/12 (2006.01) | Title | 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUORMETHYL)-2-PYRIDYL]AMINO]PYRAZIN-2-CARBONITRIL OG TERAPEUTISKE ANVENDELSER DERAF | Int. application no. | GB2013051233 | Int. publication no. | WO2013171470 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|